↓ Skip to main content

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia

Overview of attention for article published in Alzheimer's Research & Therapy, March 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
7 X users
facebook
1 Facebook page
reddit
1 Redditor

Citations

dimensions_citation
115 Dimensions

Readers on

mendeley
121 Mendeley